Diffusion-weighted magnetic resonance imaging in glioblastoma recurrence diagnosis

• A rare case of gliosarcoma: Comprehensive radiological, histopathological, and clinical insights into diagnosis and management
• Diagnostic value and efficacy of multimodal magnetic resonance imaging in differentiating radiation necrosis from tumor recurrence in glioblastomas
• Assessment of MGMT and TERT Subtypes and Prognosis of Glioblastoma by Whole Tumor Apparent Diffusion Coefficient Histogram Analysis
• Cerebral venous sinus thrombosis detected using diffusion-weighted magnetic resonance imaging during maintenance temozolomide chemotherapy in a patient with glioblastoma: illustrative case
• Diagnostic Effect of MRI Diffusion-weighted Imaging Apparent Diffusion Coefficient Value on Postoperative Recurrence of Brain Glioma
• Microstructural Abnormalities in the Contralateral Normal-appearing White Matter of Glioblastoma Patients Evaluated with Advanced Diffusion Imaging
• CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas
• Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability-an in-silico study

Diffusion-weighted magnetic resonance imaging (DWI) is a specialized MRI technique that measures the random movement (diffusion) of water molecules in tissue. It is increasingly used in the diagnosis of glioblastoma recurrence due to its ability to provide insights into tissue cellularity and the integrity of cell membranes, which change significantly in tumor recurrence.

—

Biological Basis of DWI in Glioblastoma

- Diffusion Restriction: High cellular density in recurrent glioblastoma limits water mobility, resulting in restricted diffusion, visible as hyperintense regions on DWI and low values on the apparent diffusion coefficient (ADC) map.

- Necrosis and Edema: Areas of necrosis and vasogenic edema, common in treatment-related changes (e.g., radiation necrosis), allow freer water diffusion, appearing hypointense on DWI and showing higher ADC values.

—

### Clinical Applications of DWI in Glioblastoma Recurrence

1. Differentiation Between Tumor Recurrence and Treatment-Related Changes:

1. Recurrent Tumor:
   1. DWI shows hyperintensity with low ADC values due to high tumor cellularity.
2. Radiation Necrosis:
   1. DWI shows hypointensity with high ADC values due to necrosis and tissue breakdown.

2. Early Detection:

1. DWI can detect changes in water diffusion before structural abnormalities are visible on conventional MRI, allowing earlier identification of recurrence.

3. Quantitative Thresholds:

1. Studies suggest that ADC values below a certain threshold (e.g., 1.3 × 10⁻³ mm²/s) are indicative of recurrent glioblastoma.
2. Relative ADC (rADC) can also be calculated to normalize ADC values against unaffected brain regions, improving diagnostic accuracy.

4. Guiding Biopsy or Resection:

1. DWI can localize areas of highest cellular density, assisting in targeting regions for biopsy or surgical resection.

—

### Strengths of DWI

- Non-Invasive: Provides critical insights without the need for invasive procedures. - Widely Available: Most MRI systems include DWI as a standard sequence, making it accessible in clinical practice. - Rapid Acquisition: DWI scans are quick to perform, adding minimal time to routine MRI protocols. - Early Detection of Aggressive Areas: Highlights regions with increased tumor activity before they enhance with contrast.

—

### Limitations of DWI

1. Overlap Between Tumor and Necrosis:

1. In some cases, ADC values of recurrent tumor and radiation necrosis can overlap, reducing specificity.
2. Additional imaging modalities (e.g., perfusion MRI or MRS) may be needed for confirmation.

2. Resolution Constraints:

1. DWI has lower spatial resolution compared to conventional MRI sequences, potentially missing small lesions.

3. Susceptibility Artifacts:

1. Artifacts, especially near air-tissue interfaces or in the posterior fossa, can affect image quality.

4. Limited Functional Insights:

1. While DWI assesses cellularity, it does not provide direct metabolic or vascular information, requiring complementary imaging techniques.

—

### Comparative Advantages Over Other Techniques

- Versus Conventional MRI: DWI provides functional insights into cellularity, improving differentiation between tumor recurrence and non-tumor changes. - Versus MRS: DWI is faster and more widely available but lacks metabolic specificity. - Versus Perfusion MRI: DWI is less influenced by vascular factors but may require integration with perfusion imaging for improved specificity.

—

### Future Directions

1. Integration with Advanced Imaging Techniques:

1. Combining DWI with perfusion-weighted imaging (PWI), magnetic resonance spectroscopy (MRS), or PET imaging can enhance diagnostic accuracy.

2. Machine Learning Applications:

1. AI algorithms trained on DWI data may assist in differentiating recurrent tumor from radiation necrosis with greater precision.

3. Longitudinal Monitoring:

1. Serial DWI scans could help track changes over time, offering a dynamic assessment of tumor behavior.

—

### Conclusion

DWI is a powerful tool for diagnosing glioblastoma recurrence, offering unique insights into tumor cellularity and providing a rapid, non-invasive method for evaluating post-treatment changes. While it has limitations, particularly in distinguishing between recurrent tumor and radiation necrosis, its combination with other advanced imaging modalities can improve diagnostic accuracy and patient management.